Research prototype, not medical advice.

In the AMBAR phase IIb/III trial, plasma exchange with albumin slowed decline in moderate Alzheimer on some outcomes, with mixed results.

Confidence
Debated
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Altered intercellular communicationOld plasma dilution / plasma exchange with albuminAlzheimer's disease

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
Boada et al. · Alzheimer's & Dementia 2020
— Verified